Germany's Anzag buys pharmaceutical wholesaler in Lithuania
This article was originally published in Scrip
Andreae-Noris Zahn (Anzag), the German pharmaceutical wholesaler, has signed an agreement to purchase 92% of the shares in Armila, a Lithuanian pharmaceutical wholesaler. The German company said it was expanding its business in foreign markets to reduce dependency on the domestic market where returns on sales for pharmaceutical wholesalers have been falling in recent years.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.